A study found that more than 99.8% of those evaluated had a genotype linked to a higher risk for at least one medication. RxMapper can provide patients with predicted side effects and drug response evaluation based upon their genetic makeup. Source: htt
@lisa_bastarache @uk_biobank @DMRuderfer My guess is that it would be better, but I don't know. I'm interested in CYP2D6, and from what I've seen the CNV calls from genotype data are poor. This paper called CNVs for CYP2D6 from genotype and the frequencies
RT @researchestonia: 🏆 Congratulations to researchers from @genomicstartu and @UniTartuCS for winning the ICPerMed "Best Practice in Person…
'Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations:challenges and solutions' Conocéis este artículo? https://t.co/4CqWwzk6Gu @FarmaCHUS @AnxoFF @GMXenomica @cimususc (G.BFarma) Creemos que puede resul